TSS
ACOR

Two Sigma Securities’s Acorda Therapeutics ACOR Stock Holding History

Two Sigma Securities’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,058
Closed -$82.7K – 3547
2023
Q1 		$82.7K Sell
7,058
-425
-6% -$7.06K ﹤0.01% 2227
2022
Q4 		$115K Buy
7,483
+6,339
+554% +$73.9K ﹤0.01% 2042
2022
Q3 		$7K Sell
1,144
-241
-17% -$2.02K ﹤0.01% 2456
2022
Q2 		$13K Buy
+1,385
New +$24.6K ﹤0.01% 2023
2021
Q1 		– Sell
-254
Closed -$21K – 1918
2020
Q4 		$21K Buy
+254
New +$23.4K ﹤0.01% 1604
2017
Q4 		– Sell
-77
Closed -$220K – 2085
2017
Q3 		$220K Buy
+77
New +$203K 0.02% 548

Other funds holding ACOR

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Two Sigma Securities's ACOR Position: Q2 2023 in Review

Two Sigma Securities sold out of Acorda Therapeutics (ACOR) in Q2 2023, closing a stake of 7,058 shares — an estimated $82.7K sold.

Two Sigma Securities first reported a position in ACOR in Q3 2017 and held it in 6 quarters. The position peaked at $220K in Q3 2017. 15 funds tracked by Wall St. Rank hold ACOR as of Q2 2023.

  • Two Sigma Securities reported no remaining Acorda Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Securities sold 7,058 Acorda Therapeutics shares in Q2 2023, an estimated $82.7K.
  • Two Sigma Securities first reported a position in Acorda Therapeutics in Q3 2017 and held it in 6 quarters.
  • Two Sigma Securities's Acorda Therapeutics position peaked at $220K in Q3 2017.
  • 15 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2023.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.